Site Home   Gender and Dementia       Introduction to Gender and Health   The Gender Lens Tool

Treatment True or False

1.Treatment focuses on correcting all reversible factors and preventing the progression of irreversible factors.
True     False
2.The three ChEIs marketed for treatment of mild to moderate Alzheimer's Disease in Canada are donepezil, rivastigmine and galantamine.
True     False
3.Creation of supportive environments with structure and routine to allow the individuals with dementia to function better.
True     False
4.Alzheimer's Disease patients treated with ChEIs have a modest significant therapeutic effect.
True     False
References for this Activity
1. Lanctot KL, Herrmann N, Yau KK, Khan LR, Liu BA, Loulou MM et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's Disease: a meta analysis. Canadian Medical Association Journal 2003; 169(6):557-64.
2. Luijpen MW, Scherder EJ, Van Someren EJ, Swaab DF, Sergeant JA. Non-pharmacological interventions in cognitively impaired and demented patients-a comparison with cholinesterase inhibitors. Reviews in Neurosciences 2003; 14(4):343-68.